NL-OMON47975已完成不适用
An open-label, single-sequence study to investigate the effects of gastric acid suppression by Rabeprazole on the pharmacokinetics of BMS-986165 in healthy participants - Gastric pH effect on BMS-986165
BritsolMyers Squibb Research and Development0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy male and female subjects
- •- Age of 18 to 50 years (inclusive)
- •- BMI of 18.0 to 32.0 kg/m2 (inclusive)
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. Donation of blood
- •to a blood bank or in a clinical study (except a screening visit) within 4
- •weeks of study drug administration (within 2 weeks for plasma only). Blood
- •transfusion within 4 weeks of study drug administration.
研究者
相似试验
已完成
不适用
An open-label, single-sequence study to investigate the effects of BMS-986165 on the single-dose pharmacokinetics of methotrexate in healty male subjects.Autoimmune diseases10003816NL-OMON46408Bristol-Myers Squibb Research and Development12
已完成
不适用
An Open-label, Single-Sequence Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and its Metabolites in Healthy Subjectscardiovascular eventsthrombosis10003216NL-OMON34620Eisai24
已完成
1 期
To determine whether a pharmacokinetic drug-drug interaction occurs between atorvastatin and elinogrel.chronic coronary heart disease (CHD)Cardiovascular - Coronary heart diseaseACTRN12611000315910ovartis Pharmaceutical Pty Limited28
招募中
不适用
A Study to Evaluate the Effect of Gumiganghwaltang on the Pharmacokinetics of Caffeine after Oral Administration of Caffeine in Healthy Male VolunteersDiseases of th respiratory systemKCT0001812Kyung Hee University Oriental Medical Center8
已完成
不适用
An open label, single center study to investigate the metabolic profile of dalcetrapib after a single oral dose in healthy male subjectscoronary heart disease10011082NL-OMON35295F. Hoffmann-La Roche Ltd.6